Capricor Therapeutics Statistics
NASDAQ: CAPRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
8.10+0.35 (+4.52%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Capricor Therapeutics by the numbers
Capricor Therapeutics has a market capitalization of $470.9 million based on 58.14M shares outstanding. With trailing EPS of $-2.45, Capricor Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.8% above its 50-day average and 64.0% below its 200-day average.
Average daily trading volume is 6.83M shares, or about $55.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CAPR valuation vs. peer median
| Metric | CAPR | Peer median | Difference |
|---|---|---|---|
| Market cap | $470.93M | $445.34M | +6% |
| Avg. volume | 6.83M | 489.62K | +1294% |
Peer median across 8 companies: KMDA, OVID, PRTA, ASMB, SPRY, DMAC, RZLT, CTNM.
Valuation
- Market cap
- $470.93M
- EPS (TTM)
- $-2.45
- Shares outstanding
- 58.14M
Price and trading
- Previous close
- 7.75
- Open
- 7.59
- Day range
- 7.46 – 8.27
- 52-week range
- 2.96 – 40.37
- 52-week change
- +8.00%
- Beta
- —
- Volume
- 2.84M
- Average volume
- 6.83M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 470.93M
- Forward Pe
- -5.48
- Eps
- -2.45
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 40.37
- Week52 Low
- 2.96
- Avg Volume
- 6.83M
- Shares Outstanding
- 58.14M
- Ma50
- 7.51
- Ma200
- 22.51
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -79.94%
- Pct From52w Low
- 173.65%